BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16158045)

  • 1. ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors.
    Duong V; Licznar A; Margueron R; Boulle N; Busson M; Lacroix M; Katzenellenbogen BS; Cavaillès V; Lazennec G
    Oncogene; 2006 Mar; 25(12):1799-806. PubMed ID: 16158045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
    Sundar SN; Marconett CN; Doan VB; Willoughby JA; Firestone GL
    Carcinogenesis; 2008 Dec; 29(12):2252-8. PubMed ID: 18784357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens.
    Margueron R; Duong V; Bonnet S; Escande A; Vignon F; Balaguer P; Cavaillès V
    J Mol Endocrinol; 2004 Apr; 32(2):583-94. PubMed ID: 15072561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
    Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K
    Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
    J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
    Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
    Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
    Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G.
    Zhao Z; Wang L; James T; Jung Y; Kim I; Tan R; Hoffmann FM; Xu W
    Chem Biol; 2015 Dec; 22(12):1608-21. PubMed ID: 26670079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment.
    Stettner M; Kaulfuss S; Burfeind P; Schweyer S; Strauss A; Ringert RH; Thelen P
    Mol Cancer Ther; 2007 Oct; 6(10):2626-33. PubMed ID: 17913855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
    Mafuvadze B; Liang Y; Hyder SM
    Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.
    Galea GL; Meakin LB; Sugiyama T; Zebda N; Sunters A; Taipaleenmaki H; Stein GS; van Wijnen AJ; Lanyon LE; Price JS
    J Biol Chem; 2013 Mar; 288(13):9035-48. PubMed ID: 23362266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions.
    Song D; He H; Indukuri R; Huang Z; Stepanauskaite L; Sinha I; Haldosén LA; Zhao C; Williams C
    Front Endocrinol (Lausanne); 2022; 13():930227. PubMed ID: 35872983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.
    Evers NM; van den Berg JH; Wang S; Melchers D; Houtman R; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
    J Steroid Biochem Mol Biol; 2014 Sep; 143():376-85. PubMed ID: 24923734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
    Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
    Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.